These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 26428981)

  • 1. Affordable moisturisers are effective in atopic eczema: A randomised controlled trial.
    Hlela C; Lunjani N; Gumedze F; Kakande B; Khumalo NP
    S Afr Med J; 2015 Sep; 105(9):780-4. PubMed ID: 26428981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moisturisers from birth in at-risk infants of atopic dermatitis - a pragmatic randomised controlled trial.
    Ng PSM; Wee LWY; Ho VPY; Tan WC; Bishnoi P; Alagappan U; Wong SMY; Gan EY; Quek BH; Shen L; Su B; Common JE; Koh MJA
    Australas J Dermatol; 2021 Nov; 62(4):e539-e545. PubMed ID: 34424533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial.
    Miller DW; Koch SB; Yentzer BA; Clark AR; O'Neill JR; Fountain J; Weber TM; Fleischer AB
    J Drugs Dermatol; 2011 May; 10(5):531-7. PubMed ID: 21533301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
    J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The plastic sing effect of moisturizers on human skin in vivo: a measure of moisturizing potency?
    Jemec GB; Wulf HC
    Skin Res Technol; 1998 May; 4(2):88-93. PubMed ID: 27332105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.
    Hjelmgren J; Svensson A; Jörgensen ET; Lindemalm-Lundstam B; Ragnarson Tennvall G
    Br J Dermatol; 2007 May; 156(5):913-21. PubMed ID: 17263826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bilateral comparison study of pimecrolimus cream 1% and a topical medical device cream in the treatment of patients with atopic dermatitis.
    Emer JJ; Frankel A; Sohn A; Lebwohl M
    J Drugs Dermatol; 2011 Jul; 10(7):735-43. PubMed ID: 21720655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
    Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Efficacy of Moisturisers Containing Ceramide Compared with Other Moisturisers in the Management of Atopic Dermatitis: A Systematic Literature Review and Meta-Analysis.
    Nugroho WT; Sawitri S; Astindari A; Utomo B; Listiawan MY; Ervianti E; Astari L
    Indian J Dermatol; 2023; 68(1):53-58. PubMed ID: 37151263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative trial of 5% dexpanthenol in water-in-oil formulation with 1% hydrocortisone ointment in the treatment of childhood atopic dermatitis: a pilot study.
    Udompataikul M; Limpa-o-vart D
    J Drugs Dermatol; 2012 Mar; 11(3):366-74. PubMed ID: 22395588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult patients with moderate atopic dermatitis: tacrolimus ointment versus pimecrolimus cream.
    Abramovits W; Fleischer AB; Jaracz E; Breneman D
    J Drugs Dermatol; 2008 Dec; 7(12):1153-8. PubMed ID: 19137769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
    Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
    Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
    Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proactive wet-wrap method with diluted corticosteroids versus emollients in children with atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled trial.
    Janmohamed SR; Oranje AP; Devillers AC; Rizopoulos D; van Praag MC; Van Gysel D; Goeteyn M; de Waard-van der Spek FB
    J Am Acad Dermatol; 2014 Jun; 70(6):1076-82. PubMed ID: 24698702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in patients with atopic dermatitis: impact of tacrolimus ointment.
    Kawashima M;
    Int J Dermatol; 2006 Jun; 45(6):731-6. PubMed ID: 16796638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.